A- A A+

80% of patients with ataxia telangiectasia have an immune deficiency.

The immunologist should be, with the neurologist, the referring doctor.

The doctor for prevention


Indeed, while the most visible signs in ataxia telangiectasia are neurological, danger comes mainly from the deficiency of the immune system, causing lung diseases and half of the cancers in patients with AT: leukemias and lymphomas.

Immunological check up


In case of repeated sinus or respiratory infections, immune deficiency may be suspected. The balance of immune protection is made through a blood test. It analyses:

Usually, the results found do not change with time and do not need to be repeated unless there is an increased number of infections.

Treatments


Thumbnail imageIt is not known at present how to manufacture immunoglobulins (or antibodies), especially since they are often very different and specialized in responding to a particular disease. We know however how to extract, purify and inject them without risk of rejection, since they are only molecules. This is not the case for lymphocytes for which a low rate significantly increases the risk of infection.

The arsenal available to the immunologist to treat immune deficiency is therefore limited and can not completely restore the defenses. He may propose:

  • Relevant vaccines and those who are not because the immune system would not answer to them. This is done on a case by case basis according to each deficit
  • Taking very regularly an antibiotic to target antigens whose aggression would not be supported by the damaged immune system of AT patients, to prevent lung infections for example.
  • All substances and tonics to overcome the deficiencies noticed during regular and necessary blood tests, the immunologist being the best positioned to interpret them.
  • A reminder of the basic rules for infections' prevention
  • Regular inputs of immunoglobulin to restore acceptable levels in the blood. The solution injected intravenously or subcutaneously comes from the purified plasma of thousands of donors, which were, during their lives, in contact with many diseases for which they have developed specific immunoglobulins. This way an acquired immunity is recreated in patients and will protect them partially against diseases with which they have never been in touch and for them potentially dangerous. Unfortunately, it is almost exclusively a contribution of IgG as IgA are generally poorly tolerated. The IgA (mucosal protection) and IgM are not replaced, which partly explains the increased susceptibility to lung infections retained by the treated patients. In addition, the life of these antibodies is limited (30 to 35 days) and the injections must be repeated every 2 to 4 weeks for infusions, weekly subcutaneously.

The CEREDIH


vignette_ceredih-e796bIn France, under the leadership of Professor Fisher (Necker Hospital and Scientific Committee of AT Europe) and the Association Iris, the CEREDIH is the French reference center of hereditary immune deficiencies which includes ataxia telangiectasia. This structure has a network of competence centers located throughout the country and works with the rest of Europe including the ESID (European Society of Immunodeficiency). It is a partner for families and AT Europe from the beginning.

L' AT, c'est quoi?

L'ataxie télangiectasie (AT) est une maladie rare, neurodégénérative et immunodépressive, maladie héréditaire qui affecte de nombreuses parties du corps et provoque de graves incapacités... SUITE

La recherche

La recherche sur le gène ATM en France et dans le monde. Comment combattre une maladie comme l'ataxie télangiectasie? Les projets scientifiques d'AT Europe.

Évènements

Des fêtes, des stands, des exploits, des concerts ou la mobilisation des enfants pour leurs copains... retrouvez-les tous ici! Et pour vous lancer, suivez le mode d'emploi!

Réseau ATEurope

       
 
Forgot Login?   Sign up  
Sur la course Vertigo en 2013 et 2014!
1km parcouru sur un tapis=1€! (pendant 2 jours en 2015)
Pour les Foulées du Tertre depuis 2012!
Sur l'Etape du Tour 2014!
1€ par contrat de vente en 2015 (>1000)!
Sur la course Vertigo en 2013 et 2014!

Organisez votre évènement!

Sports

Fêtes et spectacles

Stands et ventes

Règles et conseils

Ils s'engagent:

Ils sont chercheurs, sportifs, artistes ou simplement bénévoles. Leur seule motivation: redonner le sourire aux enfants d'AT Europe!

Etudes ouvertes aux familles

CEREDIH

La base de données française tenue par le CEREDIH, partenaire privilégié d'ATEurope, renferme probablement les données médicales les plus complètes au monde et toutes les mutations génétiques des personnes françaises atteintes d'AT. Parlez-en à vos médecins!

La base de données française

CURIE

Dans le cadre de la recherche d'un lien entre cancer du sein et gène ATM, l'étude CoF-AT de l'institut Curie rassemble des données sur les femmes hétérozygotes pour ce gène, c'est-à-dire porteuses saines d'une copie déficiente du gène comme peuvent l'être les mamans des enfants atteints d'AT et d'autres membres de leur famille. Faites-vous connaître!

Étude CoF-AT
de
l'institut Curie

Global AT family data project

ATCP aux USA vient de mettre en place une base de données mondiale liée à l'AT. Complémentaire de celle du CEREDIH, elle permet aux familles concernées de transmettre des données qui n'étaient pas recueillies jusque là, comme les imageries de type IRM ou scanner ou des informations liées aux aptitudes, au comportement ou encore à l'alimentation, etc. Parallèlement, un programme de recueil de 500 génomes complets est mis en place. Vous pouvez participer!

La base mondiale des autres données

Copyright © 2019 ATEurope. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.